Veterinary Medicines

Gafervit injekčný roztok

Authorised
  • Porcine normal immunoglobulin
  • Iron dextran
  • Thiamine hydrochloride
  • Riboflavin
  • Pyridoxine hydrochloride
  • Nicotinamide
  • Calcium pantothenate
  • Copper chloride
  • Cobalt(II) chloride
Download as PDF

Product identification

Medicine name:
Gafervit injekčný roztok
Active substance:
  • Porcine normal immunoglobulin
  • Iron dextran
  • Thiamine hydrochloride
  • Riboflavin
  • Pyridoxine hydrochloride
  • Nicotinamide
  • Calcium pantothenate
  • Copper chloride
  • Cobalt(II) chloride
Target species:
  • Pig (piglet)
  • Pig (suckling piglet)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine normal immunoglobulin
    5000.00
    milligram(s)
    /
    100.00
    millilitre(s)
  • Iron dextran
    700.00
    milligram(s)
    /
    100.00
    millilitre(s)
  • Thiamine hydrochloride
    3.00
    milligram(s)
    /
    100.00
    millilitre(s)
  • Riboflavin
    1.14
    milligram(s)
    /
    100.00
    millilitre(s)
  • Pyridoxine hydrochloride
    0.28
    milligram(s)
    /
    100.00
    millilitre(s)
  • Nicotinamide
    42.84
    milligram(s)
    /
    100.00
    millilitre(s)
  • Calcium pantothenate
    1.60
    milligram(s)
    /
    100.00
    millilitre(s)
  • Copper chloride
    2.71
    milligram(s)
    /
    100.00
    millilitre(s)
  • Cobalt(II) chloride
    0.27
    milligram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (piglet)
      • All relevant tissues
        0
        day
    • Pig (suckling piglet)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB03AE10
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/396/91-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 15/12/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."